Sensitivity: 33/53 (62.3%),  RASSF1A methylation of paired plasma CtDNA showed slight concordant with primary tumor samples (P = 0.227, 2-sided Pearson χ2 test, k = 0.156).  Significantly correlates with overall survival. The gene discussed is RASSF1; the disease is neoplasm.